Company / Inventory
Avalo Therapeutics, Inc. Inventory History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
-
FY2023
5-year range
$0 / $38.0K
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $38,000 to $0 over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, inventory decreased 100.0% year-over-year.
- Peak inventory was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $20.0K | -47.4% |
| FY2021 | $38.0K | +1166.7% |
| FY2020 | $3.0K | -85.9% |
| FY2019 | $21.3K | -93.3% |
| FY2018 | $317.9K | -16.8% |
| FY2017 | $382.2K | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 21, 2026